775 Phase Ib/II Study of XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) combination in metastatic melanoma refractory to prior immune checkpoint Inhibitor therapy with and without CNS disease

التفاصيل البيبلوغرافية
العنوان: 775 Phase Ib/II Study of XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) combination in metastatic melanoma refractory to prior immune checkpoint Inhibitor therapy with and without CNS disease
المؤلفون: Jacob, Saya, Micu, Markee, Quandt, Zoe, Tsai, Katy K, Yaghoubi, Shahriar, Daud, Adil
المصدر: Regular and Young Investigator Award Abstracts
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2023
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/jitc-2023-sitc2023.0775
DOI: 10.1136/jitc-2023-SITC2023.0775
الإتاحة: https://doi.org/10.1136/jitc-2023-sitc2023.0775Test
حقوق: http://creativecommons.org/licenses/by-nc/4.0Test/
رقم الانضمام: edsbas.253BFE04
قاعدة البيانات: BASE